DIN 02421208 — ONRELTEA 0.33 %
ONRELTEA is a gel of Brimonidine (Topical) marketed by GALDERMA CANADA INC.. The full Brimonidine (Topical) monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02421208
- Brand name
- ONRELTEA
- Active ingredient
- Brimonidine (Topical)
- Strength
- 0.33 %
- Dosage form
- GEL
- Route
- TOPICAL
- Manufacturer
- GALDERMA CANADA INC.
- Health Canada status
- MARKETED
- Drug class
- Topical alpha-2 adrenergic agonist (vasoconstrictor) for rosacea-associated facial erythema
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.